NovaBridge Biosciences (NBP) Current Leases (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Current Leases of $891000.0 for Q4 2025, up 9.19% year-on-year from $816000.0 in Q4 2024, and up 2.18% on a QoQ basis from $872000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Current Leases (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Current Leases for 7 consecutive years, with $891000.0 the latest figure, recorded in Q4 2025.
- Quarterly Current Leases rose 9.19% year-over-year to $891000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $891000.0 (up 9.19% YoY) and the FY2025 annual result came in at $891000.0, up 9.19% from the prior year.
- Current Leases rose to $891000.0 in Q4 2025 per NBP's latest filing, from $872000.0 in the prior quarter.
- Over the last five years, Current Leases for NBP reached as high as $4.8 billion in Q4 2021 and fell as low as $737000.0 in Q2 2024.
- A 5-year average of $370.8 million and a median of $891000.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases soared 394417.06% — and 2022, when it sank 99.93%.
- Year by year, Current Leases stood at $4.8 billion in 2021, then plunged by 99.93% to $3.4 million in 2022, then retreated by 9.76% to $3.0 million in 2023, then sank by 73.16% to $816000.0 in 2024, then increased by 9.19% to $891000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $891000.0, $872000.0, and $853000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | 891,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 891,000.00 |
| Sep 30, 2025 | 872,000.00 |
| Jun 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 835,000.00 |
| Dec 31, 2024 | 816,000.00 |
| Sep 30, 2024 | 753,000.00 |
| Jun 30, 2024 | 737,000.00 |
| Dec 31, 2023 | 3.04 Mn |
| Jun 30, 2023 | 3.77 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Dec 31, 2021 | 4.80 Bn |
| Jun 30, 2021 | 1.53 Mn |
| Dec 31, 2020 | 1.22 Mn |
| Sep 30, 2020 | 1.18 Mn |
| Jun 30, 2020 | 1.16 Mn |
| Dec 31, 2019 | 965,782.40 |